PRESS RELEASE Immunocore to present at upcoming investor conferences (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR)
Fireside Chat: Wednesday, June 9, 2021 at 10:30 am ET
The investor conferences will each be held in a virtual format and a live webcast of each fireside chat can be accessed in the ‘Investors’ section of Immunocore’s website at www.immunocore.com. For conferences that offer replays, presentations will be made available for a limited time.
##
About Immunocore
Immunocore is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, infectious and autoimmune. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. Immunocore’s most ad
Message :
Required fields
Anthem, Inc. (NYSE: ANTM) announced today that senior management is scheduled to present at the Alliance Bernstein 37th Annual Strategic Decisions Conference on June 4, 2021, at 10:00 a.m. Eastern Daylight Time (EDT). Senior management is also scheduled to present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8 at 10:30 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a webcast of these presentations by visiting www.antheminc.com and selecting the “Investors” link. Following each presentation, a webcast replay will be available for two weeks.
To listen to the live webcast, we recommend visiting Anthem’s website 15 minutes prior to the event to download and install any necessary audio software. Individuals who listen to the presentations will be presumed to have read Anthem s most recent filings with the SEC, including but not limited to its Annual Report on Form 10-K for the year ended Decembe
NeoGenomics, Inc.: NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences
FT MYERS, FL / ACCESSWIRE / May 27, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that senior management will be participating virtually in multiple upcoming institutional investor conferences.
Management will participate in investor meetings at the 18th Annual Craig-Hallum Institutional Investor Conference on Wednesday, June 2
nd.
Management will participate in investor meetings and a fireside chat at William Blair s 41st Annual Growth Stock Conference on Thursday, June 3
rd. The fireside chat discussion is scheduled for 10:20am ET and will be webcast live.
NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.